The economic burden of visual impairment and blindness: A systematic review

BMJ Open

Volumn 3, Issue 11, 2013, Pages

  Köberlein, Juliane ^a   Beifus, Karolina ^a   Schaffert, Corinna ^a   Finger, Robert P ^b,c  

^a UNIVERSITY OF WUPPERTAL   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BLINDNESS; CANADA; CAREGIVER; COST OF ILLNESS; DAILY LIFE ACTIVITY; DEPENDENT PERSONALITY DISORDER; DEPRESSION; EMOTIONAL STRESS; EMPLOYMENT STATUS; FALL RISK; FRANCE; GERMANY; HOSPITALIZATION COST; HUMAN; JAPAN; LOW VISION; MEDICAL SERVICE; MONOCULAR VISION; REFRACTION ERROR; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84888110483     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003471     Document Type: Article

References (47)

1. Finger RP, Fimmers R, Holz FG, et al. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci 2011;52:4381-9.
2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
3. Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514-20. (Pubitemid 28169754)
4. Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol 2006;90:272-5. (Pubitemid 43325453)
5. Drummond MF. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005.
6. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
7. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990;6:57-75. (Pubitemid 20287161)
8. Ament A, Evers S. Cost of illness studies in health care: a comparison of two cases. Health Policy 1993;26:29-42. (Pubitemid 24010094)
9. Emmert M, Huber M, Schöffski O. Eine Aggregation von Instrumenten zur Qualitätsbewertung gesundheitsökonomischer Evalutionsstudien. Pharmacoeconomics 2011:11-30.
10. Brennan RL, Prediger DJ. Coefficient Kappa: some uses, misuses, and alternatives. 1981;6:87-99.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
12. The World Bank: GDP deflator-World development Indicators. Access date 2013-04-08 2013 [cited 2013 8 Apr. 2013]. http://data. worldbank.org/indicator/ NY. GDP. DEFL. KD. ZG/countries
13. Frick KD, Kymes SM, Lee PP, et al. The cost of visual impairment: purposes, perspectives, and guidance. Invest Ophthalmol Vis Sci 2010;51:1801-5.
14. OECD. Health policies and data: OECD Health Data 2012. 2012.
15. Bramley T, Peeples P, Walt JG, et al. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol 2008;126:849-56. (Pubitemid 351831337)
16. Brezin AP, Lafuma A, Fagnani F, et al. Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol 2005;123:1117-24. (Pubitemid 41159308)
17. Chou SL, Lamoureux E, Keeffe J. Methods for measuring personal costs associated with vision impairment. Ophthalmic Epidemiol 2006;13:355-63. (Pubitemid 44973610)
18. Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Med 2003;20:442-50. (Pubitemid 36776003)
19. Cruess AF, Gordon KD, Bellan L, et al. The cost of vision loss in Canada.2. Results. Can J Ophthalmol 2011;46:315-18.
20. Gordon KD, Cruess AF, Bellan L, et al. The cost of vision loss in Canada.1. Methodology. Can J Ophthalmol 2011;46:310-14.
21. Frick KD, Walt JG, Chiang TH, et al. Direct costs of blindness experienced by patients enrolled in managed care. Ophthalmology 2008;115:11-17. (Pubitemid 350309399)
22. Frick K, Gower EW, Kempen JH, et al. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 2007;125:544-50. (Pubitemid 46596727)
23. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology 2007;114:238-45.
24. Keeffe JE, Chou SL, Lamoureux EL. The cost of care for people with impaired vision in Australia. Arch Ophthalmol 2009;127:1377-81.
25. Kymes SM, Plotzke MR, Li JZ, et al. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach. Am J Ophthalmol 2010;150:74-81.
26. Lafuma A, Brezin A, Fagnani F, et al. Nonmedical economic consequences attributable to visual impairment: a nation-wide approach in France. Eur J Health Econ 2006;7:158-64. (Pubitemid 44581780)
27. McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5 year mortality. Br J Ophthalmol 2001;85:322-6. (Pubitemid 32250763)
28. Morse AR, Yatzkan E, Berberich B, et al. Acute care hospital utilization by patients with visual impairment. Arch Ophthalmol 1999;117:943-9. (Pubitemid 29330783)
29. Porz G, Scholl HP, Holz FG, et al. [Methods for estimating personal costs of disease using retinal diseases as an example]. Ophthalmologe 2010;107:216-20, 22.
30. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754-60. (Pubitemid 44920172)
31. Roberts CB, Hiratsuka Y, Yamada M, et al. Economic cost of visual impairment in Japan. Arch Ophthalmol 2010;128:766-71.
32. Schmier JK, Covert DW, Matthews GP, et al. Impact of visual impairment on service and device use by individuals with diabetic retinopathy. Disabil Rehabil 2009;31:659-65.
33. Schmier JK, Halpern MT, Covert D, et al. Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration. Retina 2006;26:1056-62. (Pubitemid 44973226)
34. Vu HT, Keeffe JE, McCarty CA, et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005;89:360-3. (Pubitemid 40327623)
35. Wong EY, Chou SL, Lamoureux EL, et al. Personal costs of visual impairment by different eye diseases and severity of visual loss. Ophthalmic Epidemiol 2008;15:339-44.
36. Wood JM, Lacherez P, Black AA, et al. Risk of falls, injurious falls, and other injuries resulting from visual impairment among older adults with age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:5088-92.
37. Koster I, Von Ferber L, Ihle P, et al. The cost burden of diabetes mellitus: the evidence from Germany-the CoDi M Study. Diabetologia 2006;49:1498-504. (Pubitemid 43848085)
38. Dewey HM, Thrift AG, Mihalopoulos C, et al. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2001;32:2409-16. (Pubitemid 32958558)
39. Henriksson F, Jonsson B. Diabetes: the cost of illness in Sweden. J Intern Med 1998;244:461-8. (Pubitemid 28552852)
40. Van Tulder MW, Koes BW, Bouter LM. A cost-of-illness study of back pain in the Netherlands. Pain 1995;62:233-40.
41. Finger RP, Fenwick E, Chiang PP, et al. The impact of the severity of vision loss on vision-specific functioning in a German outpatient population-an observational study. Graefes Arch Clin Exp Ophthalmol 2011;249:1245-53.
42. Finger RP, Fenwick E, Marella M, et al. The impact of vision impairment on vision-specific quality of life in Germany. Invest Ophthalmol Vis Sci 2011;52:3613-19.
43. Lamoureux EL, Chong E, Wang JJ, et al. Visual impairment, causes of vision loss, and falls: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci 2008;49:528-33.
44. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002;120:1041-4. (Pubitemid 34856071)
45. Horowitz A, Reinhardt JP, Boerner K, et al. The influence of health, social support quality and rehabilitation on depression among disabled elders. Aging Ment Health 2003;7:342-50. (Pubitemid 37070942)
46. Tolman J, Hill RD, Kleinschmidt JJ, et al. Psychosocial adaptation to visual impairment and its relationship to depressive affect in older adults with age-related macular degeneration. Gerontologist 2005;45:747-53. (Pubitemid 41759780)
47. Bloom BS, Bruno DJ, Maman DY, et al. Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 2001;19:207-13. (Pubitemid 32176473)